Literature DB >> 8309480

Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes.

B J Rogerson1.   

Abstract

Mammalian B-cell specific somatic hypermutation contributes to affinity maturation of the antibody response. This mutator activity is highly focused on rearranged immunoglobulin variable regions, but the underlying mechanism remains to be elucidated. In an effort to gain insights into the mechanism of somatic hypermutation, the precise distribution and frequency of mutations upstream of murine immunoglobulin genes was determined by examining the same variable gene segments when mutated in different B-cell lines. Immunoglobulin sequences analysed included kappa light chain transgenes bearing mutated V kappa 24 variable regions, and the endogenous V kappa gene isolated from myeloma MOPC167, which also exhibits mutations in the variable region. In addition, mutated endogenous VH1 gene segments of the S107 heavy chain variable gene family were also examined. For both VH1 and V kappa 24, somatic mutations were generally not found upstream of the leader intron, even in genes which exhibited a high mutation frequency in the variable region itself. The 5' somatic mutation boundary identified in immunoglobulin transgenes overlaps the boundary observed in endogenous genes, suggesting that both share cis-elements required for defining the mutable domain. Furthermore, the location of this 5' boundary appears not to change when these immunoglobulin genes are examined in different cell lines. These data may be indicative of a defined start site for immunoglobulin mutator activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8309480     DOI: 10.1016/0161-5890(94)90081-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  17 in total

1.  The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.

Authors:  C Rada; C Milstein
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 2.  Somatic immunoglobulin hypermutation.

Authors:  Marilyn Diaz; Paolo Casali
Journal:  Curr Opin Immunol       Date:  2002-04       Impact factor: 7.486

Review 3.  DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation.

Authors:  Zhenming Xu; Zsolt Fulop; Yuan Zhong; Albert J Evinger; Hong Zan; Paolo Casali
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

4.  Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.

Authors:  Atsumasa Komori; Zhenming Xu; Xiaoping Wu; Hong Zan; Paolo Casali
Journal:  Mol Immunol       Date:  2006-01-10       Impact factor: 4.407

5.  Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation.

Authors:  B Goyenechea; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  An immunoglobulin mutator that targets G.C base pairs.

Authors:  J Bachl; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Human B cells accumulate immunoglobulin V gene somatic mutations in a cell contact-dependent manner in cultures supported by activated T cells but not in cultures supported by CD40 ligand.

Authors:  S C Huang; A M Glas; G V Pinchuk; E H Van Montfort; S P Rao; R Jiang; E C Milner
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 8.  Immunoglobulin somatic hypermutation: double-strand DNA breaks, AID and error-prone DNA repair.

Authors:  Xiaoping Wu; Junli Feng; Atsumasa Komori; Edmund C Kim; Hong Zan; Paolo Casali
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

9.  The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription.

Authors:  Hong Ming Shen; Michael G Poirier; Michael J Allen; Justin North; Ratnesh Lal; Jonathan Widom; Ursula Storb
Journal:  J Exp Med       Date:  2009-04-20       Impact factor: 14.307

10.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.